354 institutions reported holding $3.70B of ULTRAGENYX PHARMACEUTICAL IN (RARE) in SEC 13F filings for 2026-06-30. Largest institutional holders: VANGUARD GROUP INC ($397.7M), BlackRock, Inc. ($355.7M), RTW INVESTMENTS, LP ($260.3M), AQR CAPITAL MANAGEMENT LLC ($214.1M), STATE STREET CORP ($205.6M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30